SEC Contract Filing

Filing Date: 2024-04-01

Document Content:
<DOCUMENT>
<TYPE>EX-10.57
<SEQUENCE>8
<FILENAME>gdnsf-20231231xex10d57.htm
<DESCRIPTION>EX-10.57
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge 10.5.122.0--><!--Created on: 4/1/2024 06:22:19 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:12pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:none;">EXHIBIT 10.57</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-weight:bold;text-align:center;text-transform:uppercase;margin:0pt 0pt 12pt 0pt;">GOODNESS GROWTH HOLDINGS, INC. <br>NON-STATUTORY STOCK OPTION AGREEMENT</p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin-bottom:12pt;margin-left:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-weight:bold;min-width:36pt;text-decoration-line:none;white-space:nowrap;">I.</font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">NOTICE OF GRANT</b></div><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Name of Optionee:<font style="display:inline-block;width:23.7pt;"></font><font style="display:inline-block;width:36pt;"></font>John Heller </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Number of Shares:<font style="display:inline-block;width:24.91pt;"></font><font style="display:inline-block;width:36pt;"></font>287,888 Subordinate Voting Shares </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-align:left;text-indent:0pt;width:72pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;font-style:normal;font-weight:normal;">Date of Grant:</font></font><font style="display:inline-block;width:36pt;"></font><font style="display:inline-block;width:36pt;"></font>June 7, 2023 </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Exercise Price per Share:<font style="display:inline-block;width:33.13pt;"></font>USD$0.1757 </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Expiration Date:<font style="display:inline-block;width:35pt;"></font><font style="display:inline-block;width:36pt;"></font>June 6, 2033 (5:00 p.m., Central Time)</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Exercise Schedule: Subject to Section 4 hereof: (1) 71,972 of the Shares covered by the Option are vested upon grant and immediately exercisable; (2) 17,993 of the Shares covered by the Option shall become exercisable and vest on June 30, 2023; (3) an additional 17,993 of the Shares covered by the Option shall become exercisable and vest on the last day of each calendar quarter thereafter through March 31, 2026; such that all Shares covered by the Option shall be exercisable on March 31, 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">This is non-statutory Stock Option Agreement (the &#8220;<font style="font-style:italic;font-weight:bold;">Agreement</font>&#8221;), by and between Goodness Growth Holdings, Inc., a British Columbia corporation formerly known as Vireo Health International, Inc., and successor to Vireo Health, Inc. (the &#8220;<font style="font-style:italic;font-weight:bold;">Company</font>&#8221;), and the Optionee entered into and effective as of date of grant identified above (the &#8220;<font style="font-style:italic;font-weight:bold;">Date of Grant</font>&#8221;).</p><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin-bottom:12pt;margin-left:0pt;text-align:justify;text-indent:0pt;"><font style="display:inline-block;font-weight:bold;min-width:36pt;text-decoration-line:none;white-space:nowrap;">II.</font><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">BACKGROUND</b></div><div style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin-bottom:12pt;margin-left:0pt;text-align:justify;text-indent:36pt;"><font style="display:inline-block;min-width:36pt;text-decoration-line:none;text-indent:0pt;white-space:nowrap;">1.</font>The Company and the Optionee entered into an Employment Agreement dated December&#160;1, 2020 (the &#8220;<font style="font-style:italic;font-weight:bold;">Original Agreement</font>&#8221;), as amended by a First Amendment to Employment Agreement Agreement dated February 2, 2022 (the &#8220;<font style="font-style:italic;font-weight:bold;">First Amendment</font>&#8221;), a Second Amendment to Employment Agreement dated December 14, 2022 (the &#8220;<font style="font-style:italic;font-weight:bold;">Second Amendment</font>&#8221;), and a Third Amendment to Employment Agreement dated June 6, 2023 (the &#8220;<font style="font-style:italic;font-weight:bold;">Third Amendment</font>&#8221; and, collectively with the Original Agreement, the First Amendment, and the Second Amendment, the &#8220;<font style="font-style:italic;font-weight:bold;">Employment Agreement</font>&#8221;).</div><div style="fo